Status: Recruiting
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
The objectives of this registry study are to: 1. Record real-life data related to the use of the ARTICE® therapy in sepsis subjects. 2. Further evaluate ARTICE® treatment efficacy. 3. Identify potential sub-groups, assess their risk-benefit- and safety profile. 4. Changes in SOFA score D0 to SOFA Score D7.
Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Artcline GmbHUpdated: Feb 9, 2026Locations: 1Duration: 7 Days
Eligibility criteria
Subjects ≥ 18 years who are planned to receive ARTICE® treatment during their IC...